Literature DB >> 2821125

Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy.

A A Medeiros1, T F O'Brien, E Y Rosenberg, H Nikaido.   

Abstract

Minimal inhibitory concentrations of cephalosporins for a strain of Salmonella typhimurium from one patient increased severalfold after starting therapy with cephalexin. The first isolate with increased resistance (S20323) and an earlier, less resistant isolate (S17069) each had a TEM-1 beta-lactamase with similar Vmax and Km values. Intact cells of S20323 grown in a high osmolality medium hydrolyzed cephalosporin substrates much more slowly than did intact cells of S17069 at low substrate concentrations, a result indicating slower diffusion of cephalosporins into S20323. In low osmolality media, S17069 produced both OmpF and OmpC porins; S20323 produced only OmpF porin. In high osmolality media with osmotic activity similar to that in the patient's tissues, synthesis of the OmpF porin was repressed in both strains and left S20323 with undetectably low levels of any porin. The increased beta-lactam resistance in S20323 is apparently a consequence of the loss of the OmpC porin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821125     DOI: 10.1093/infdis/156.5.751

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 2.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system.

Authors:  Wensi S Hu; Pei-Chuan Li; Chao-Yin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.

Authors:  Wensi S Hu; Jing-Fang Lin; Ying-Hsiu Lin; Hsin-Yu Chang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

5.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 6.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 7.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during beta-lactam therapy.

Authors:  F Bellido; I R Vladoïanu; R Auckenthaler; S Suter; P Wacker; R L Then; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

9.  Genome wide evolutionary analyses reveal serotype specific patterns of positive selection in selected Salmonella serotypes.

Authors:  Yeşim Soyer; Renato H Orsi; Lorraine D Rodriguez-Rivera; Qi Sun; Martin Wiedmann
Journal:  BMC Evol Biol       Date:  2009-11-14       Impact factor: 3.260

10.  Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.

Authors:  Anna Fàbrega; Laurence du Merle; Chantal Le Bouguénec; M Teresa Jiménez de Anta; Jordi Vila
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.